Certican is an immunosuppressant prescribed to prevent organ rejection after heart, liver, or kidney transplants. It contains everolimus, which works to suppress immune system activity and reduce the proliferation of cells responsible for organ rejection. This helps stabilize the patient's health and increases the chances of successful surgery. It is always used under close medical supervision as part of a comprehensive post-transplant treatment protocol.
This combination works to achieve immune balance, protecting the patient from serious complications. Certican helps reduce relapses and improve the long-term performance of the transplanted organ. It also helps reduce reliance on other immunosuppressants with severe side effects. It is important to adhere to the prescribed doses and conduct periodic tests to monitor drug levels in the blood, ensuring optimal results and maintaining patient health.